Axonics Gross Margin 2017-2023 | AXNX
Axonics Gross Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Gross Profit | Gross Margin |
2023-12-31 | $0.37B | $0.28B | 74.93% |
2023-09-30 | $0.34B | $0.26B | 74.34% |
2023-06-30 | $0.32B | $0.24B | 74.06% |
2023-03-31 | $0.30B | $0.22B | 73.31% |
2022-12-31 | $0.27B | $0.20B | 72.16% |
2022-09-30 | $0.24B | $0.17B | 70.42% |
2022-06-30 | $0.22B | $0.15B | 68.66% |
2022-03-31 | $0.19B | $0.13B | 65.98% |
2021-12-31 | $0.18B | $0.12B | 63.89% |
2021-09-30 | $0.16B | $0.10B | 62.96% |
2021-06-30 | $0.15B | $0.09B | 62.00% |
2021-03-31 | $0.12B | $0.07B | 59.66% |
2020-12-31 | $0.11B | $0.07B | 60.36% |
2020-09-30 | $0.09B | $0.05B | 58.14% |
2020-06-30 | $0.05B | $0.03B | 55.77% |
2020-03-31 | $0.04B | $0.02B | 60.53% |
2019-12-31 | $0.01B | $0.01B | 61.54% |
2019-09-30 | $0.00B | $0.00B | 100.00% |
2019-06-30 | $0.00B | $0.00B | 100.00% |
2019-03-31 | $0.00B | $0.00B | 100.00% |
2018-06-30 | $0.00B | 0 | nan% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $3.390B | $0.366B |
Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
Inspire Medical Systems (INSP) | United States | $7.087B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.621B | 0.00 |
10x Genomics (TXG) | United States | $3.287B | 0.00 |
Enovis (ENOV) | United States | $3.042B | 23.11 |
Azenta (AZTA) | United States | $2.930B | 238.82 |
Olink Holding AB (publ) (OLK) | Sweden | $2.760B | 0.00 |
Hims & Hers Health (HIMS) | United States | $2.642B | 0.00 |
Privia Health (PRVA) | United States | $2.231B | 98.95 |
Schrodinger (SDGR) | United States | $1.794B | 0.00 |
Omnicell (OMCL) | United States | $1.306B | 31.94 |
Phreesia (PHR) | United States | $1.305B | 0.00 |
Definitive Healthcare (DH) | United States | $0.856B | 0.00 |
Standard BioTools (LAB) | United States | $0.743B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.617B | 0.00 |
Talkspace (TALK) | United States | $0.530B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.330B | 0.00 |
Health Catalyst (HCAT) | United States | $0.328B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.312B | 0.00 |
Pulmonx (LUNG) | United States | $0.289B | 0.00 |
P3 Health Partners (PIII) | United States | $0.162B | 0.00 |
MSP Recovery (LIFW) | United States | $0.158B | 0.00 |
American Well (AMWL) | United States | $0.157B | 0.00 |
Butterfly Network (BFLY) | United States | $0.154B | 0.00 |
Augmedix (AUGX) | United States | $0.138B | 0.00 |
Outset Medical (OM) | United States | $0.127B | 0.00 |
TruBridge (TBRG) | United States | $0.119B | 5.06 |
111 (YI) | China | $0.091B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.079B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
HeartBeam (BEAT) | United States | $0.054B | 0.00 |
Zepp Health (ZEPP) | China | $0.052B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
Movano (MOVE) | United States | $0.027B | 0.00 |
Cue Health (HLTH) | United States | $0.024B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.019B | 0.00 |
Akili (AKLI) | United States | $0.019B | 0.00 |
CareCloud (CCLD) | United States | $0.018B | 0.00 |
ETAO (ETAO) | United States | $0.015B | 0.00 |
Biotricity (BTCY) | United States | $0.014B | 0.00 |
Centogene (CNTG) | Germany | $0.013B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Syra Health (SYRA) | United States | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |